Assessment for Acquired Pyruvate Kinase Deficiency
Characterization Of Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Observational Trial
- Enrollment
- 100 patients (estimated)
- Sponsors
- Massachusetts General Hospital
- Collaborators
- Agios Pharmaceuticals, Inc.
- Tags
- Laboratory Assay
- Trial Type
- Observational
- Last Update
- 3 months ago
- SparkCures ID
- 1630
- NCT Identifier
- NCT04902833
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.